Improving Minority Health in Rheumatic Diseases

改善少数民族风湿病健康

基本信息

  • 批准号:
    9902868
  • 负责人:
  • 金额:
    $ 55.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-25 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Systemic Lupus Erythematosus is a significant chronic disease with morbidity and mortality in primarily young women of color. Our current P30 CCCR grant “Improving Minority Health in Rheumatic Diseases” is composed of three cores, administrative, methodology and patient resource. These cores provide the infrastructure for studies directed at understanding the pathogenesis of lupus and scleroderma as a method to achieve better diagnostics and treatments for these diseases. In this Administrative Supplement to the P30 we are proposing two specific projects focused on decreasing ethnic disparities in lupus to be performed at MUSC and the University of Alabama at Birmingham. The first project is to provide awareness, education and early screening in young African American females through programs and efforts at Historically Black Colleges and Universities in South Carolina and Alabama. The second project is to utilize a patient advocate for high risk African American female lupus patients based on missed appointments, medication non adherence and ER visits at both institutions. The advocate will work with the patients to improve these parameters believing that such navigation in lupus will be as successful as similar efforts in HIV. We also propose an enhancement effort consisting of a pilot project each year for both institutions, a mentoring program for junior investigators in health disparities and cross institutional sharing of expertise. The CCCR program does not include projects, but only cores. We propose to utilize this supplement mechanism to pursue projects we believe will have direct impact on ethnic disparities in lupus.
摘要 系统性红斑狼疮是一种重要的慢性疾病, 主要是有色人种的年轻女性。我们目前的P30 CCCR赠款“改善少数民族健康, “风湿病”由三个核心组成,即管理、方法和病人资源。 这些核心为旨在了解狼疮发病机制的研究提供了基础设施 和硬皮病作为实现对这些疾病的更好诊断和治疗的方法。在 在P30的这份行政补充中,我们提出了两个重点关注的具体项目 减少狼疮的种族差异将在MUSC和亚拉巴马大学进行, 伯明翰第一个项目是在年轻人中提供认识、教育和早期筛查, 非洲裔美国女性通过在历史上黑人学院的方案和努力, 南卡罗来纳州和亚拉巴马的大学。第二个项目是利用病人的倡导者, 高风险非洲裔美国女性狼疮患者基于错过的预约,药物治疗, 这两个机构的依从性和急诊室就诊。倡导者将与患者一起改善 这些参数相信,在狼疮中的这种导航将与在 艾滋病。我们还建议每年开展一个试点项目, 机构,为初级研究人员在健康差距和跨机构的指导计划 分享专业知识。CCCR计划不包括项目,而只包括核心。我们建议 利用这一补充机制,实施我们认为将对族裔群体产生直接影响的项目。 狼疮的差异

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary S Gilkeson其他文献

Podocytes: A Potential Source of Nitric Oxide Production in Murine Lupus Nephritis
  • DOI:
    10.1016/j.freeradbiomed.2010.10.406
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ahmad K Mashmoushi;Ann F Hofbauer;Gary S Gilkeson;Jim C Oates
  • 通讯作者:
    Jim C Oates
Role of Nitric Oxide in Podocyte Physiology in Lupus Nephritis
  • DOI:
    10.1016/j.freeradbiomed.2012.10.228
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ahmad K Mashmoushi;Ann F Hofbauer;Gary S Gilkeson;Jim C Oates
  • 通讯作者:
    Jim C Oates
Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages
  • DOI:
    10.1136/annrheumdis-2021-220793.
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
  • 作者:
    Linyu Geng;Jian Zhao;Yun Deng;Ivan Molano;Xue Xu;Lingxiao Xu;Phillip Ruiz;Quanzhen Li;Xuebing Feng;Miaojia Zhang;Wenfeng Tan;Diane L Kamen;San-Cheol Bae;Gary S Gilkeson;Lingyun Sun;Betty P Tsao
  • 通讯作者:
    Betty P Tsao
PSS61 - Nitric Oxide Modulation of Redox-Modulated Cytokines in Lupus Nephritis
  • DOI:
    10.1016/j.freeradbiomed.2013.10.476
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jim C Oates;Ahmad K Mashmoushi;Ann F Hofbauer;Gary S Gilkeson
  • 通讯作者:
    Gary S Gilkeson
Human SLE variant emNCF1/em-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages
人类系统性红斑狼疮变异体 emNCF1/em-R90H 通过巨噬细胞吞噬缺陷导致的 Tfh2 反应增强促进肾脏损伤和小鼠狼疮
  • DOI:
    10.1136/annrheumdis-2021-220793
  • 发表时间:
    2022-02-01
  • 期刊:
  • 影响因子:
    20.600
  • 作者:
    Linyu Geng;Jian Zhao;Yun Deng;Ivan Molano;Xue Xu;Lingxiao Xu;Phillip Ruiz;Quanzhen Li;Xuebing Feng;Miaojia Zhang;Wenfeng Tan;Diane L Kamen;Sang-Cheol Bae;Gary S Gilkeson;Lingyun Sun;Betty P Tsao
  • 通讯作者:
    Betty P Tsao

Gary S Gilkeson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary S Gilkeson', 18)}}的其他基金

A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
同种异体间充质干细胞治疗难治性狼疮的 II 期对照试验
  • 批准号:
    10827646
  • 财政年份:
    2018
  • 资助金额:
    $ 55.05万
  • 项目类别:
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
同种异体间充质干细胞治疗难治性狼疮的 II 期对照试验
  • 批准号:
    10356843
  • 财政年份:
    2018
  • 资助金额:
    $ 55.05万
  • 项目类别:
Improving Minority Health in Rheumatic Diseases
改善少数民族风湿病健康
  • 批准号:
    10254241
  • 财政年份:
    2017
  • 资助金额:
    $ 55.05万
  • 项目类别:
Improving Minority Health in Rheumatic Diseases
改善少数民族风湿病健康
  • 批准号:
    9413805
  • 财政年份:
    2017
  • 资助金额:
    $ 55.05万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10254245
  • 财政年份:
    2017
  • 资助金额:
    $ 55.05万
  • 项目类别:
Role of Gut Microbial Translocation in Initiating Autoimmunity
肠道微生物易位在启动自身免疫中的作用
  • 批准号:
    10291780
  • 财政年份:
    2014
  • 资助金额:
    $ 55.05万
  • 项目类别:
Role of Gut Microbial Translocation in Initiating Autoimmunity
肠道微生物易位在启动自身免疫中的作用
  • 批准号:
    9564333
  • 财政年份:
    2014
  • 资助金额:
    $ 55.05万
  • 项目类别:
Mesenchymal Stem Cell Therapy for Active Systemic Lupus Erythematosus
间充质干细胞治疗活动性系统性红斑狼疮
  • 批准号:
    8791443
  • 财政年份:
    2014
  • 资助金额:
    $ 55.05万
  • 项目类别:
Sex Differences in Gut Permeability; Impact on Autoimmunity
肠道渗透性的性别差异;
  • 批准号:
    8958705
  • 财政年份:
    2014
  • 资助金额:
    $ 55.05万
  • 项目类别:
Sex Differences in Gut Permeability; Impact on Autoimmunity
肠道渗透性的性别差异;
  • 批准号:
    8820340
  • 财政年份:
    2014
  • 资助金额:
    $ 55.05万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 55.05万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了